Shares of SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) were down 6.7% on Friday . The company traded as low as $1.82 and last traded at $1.82. Approximately 70,909 shares changed hands ...

Contestants in the Stony Brook University challenge described their connection with women who sometimes operated in the ...

Scientists have identified a tiny genetic change—present in nearly all living humans but absent in our closest extinct ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for ...

The Noonan lab at Yale University is focused on understanding how HARs contribute to the evolution of uniquely human brain features.

A robotic device allows eye surgeons to perform high-precision procedures on the retina, the fragile lining on the back of the eye that is less than a millimeter thick.

GeneDx excels in comprehensive genome and exome testing using a vast genetic database linking 400+ diseases. See why I think ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects. The study is published in the QJM ...

Researchers have identified genetic variants that may affect how well individuals respond to varenicline, a drug used for smoking cessation. Research reveals that certain genes may affect the ...

Tanks have dominated battlefields for over a century, but not all designs were built for success. From engineering blunders to battlefield legends, this is how tanks became the monsters of war!